We. Russell et al., LIVER-REGENERATION AND HEPATOCARCINOGENESIS IN TRANSFORMING GROWTH FACTOR-ALPHA-TARGETED MICE, Molecular carcinogenesis, 15(3), 1996, pp. 183-189
Transforming growth factor-alpha (TGF alpha), a member of the epiderma
l growth factor receptor ligand family, has been implicated in the reg
eneration and transformation of liver. Our recent development of mice
that are homozygous for a disrupted TGF alpha gene allowed us to asses
s the requirement for this growth factor in these complex processes. W
e report here that although a 70% hepatectomy produced a significant i
ncrease in hepatic TGF alpha protein levels in wild-type mice, liver r
egeneration nevertheless proceeded normally in the absence of the grow
th factor. The hepatocyte labeling indices determined for homozygous t
argeted and wild-type mice at 36 and 48 h after hepatectomy were compa
rable, and the total liver DNA to body weight ratios 8 d after hepatec
tomy were essentially identical for the two genotypes. These results i
ndicate that TGF alpha is not necessary for liver regeneration. To tes
t its requirement in liver carcinogenesis, young mice were administere
d single doses of diethylnitrosamine (DEN) with or without subsequent
chronic treatment with the promoting agent phenobarbital (PB). Both wi
ld-type and homozygous mutant male mice treated with DEN or DEN plus P
B developed multiple preneoplastic foci or tumors by 9 mo of age with
relatively high incidence. However, while five of 88 tumors in wild-ty
pe mice attained a diameter greater than 5 mm and were classified as h
epatocellular carcinomas, none of 132 tumors in livers of targeted mic
e reached this size. Furthermore, three of these large wild-type tumor
s expressed significantly elevated levels of TGF alpha protein compare
d with normal liver. These results indicate that TGF alpha is not requ
ired for early events in chemically induced hepatocarcinogenesis but s
uggest that it could be important in the progression from small preneo
plastic foci to large tumors. (C) 1996 Wiley-Liss, Inc.